leisure time -WSS

leisure time

author：hotspot 2025-10-02 09:47:20 - browse：29

Tortoise and hare — Medical devices have historically been seen as having faster paths to market than their pharmacological counterparts. The growing requirement for cost-effectiveness trials may be slowing them down. Jonathan Elderfield/AP

When a colleague and I started our medical device company in 2009, we were in our second year at Harvard Medical School. Some classmates joked that they would still be in residency by the time we had moved on to our next big idea. We knew better — we expected it to be a long haul. Eight years into our journey, thousands of individuals have used our product in countries where it has been approved. But we have yet to gain approval in the U.S. — a long and expensive process.

In 2016, the United States Food and Drug Administration approved 22 new drugs, down from 45 approvals in 2015. The decline in drug discovery has been attributed to a variety of factors that include ballooning research and development expenses (the cost to develop a new drug is now estimated to be more than $2.5 billion), high rates of failure (a whopping 90 percent of Phase 1 candidates never make it to launch), and the complexity of human biology, which can thwart even the most promising candidates.

Medical devices have historically been viewed as having faster and lower-cost paths to market than their pharmacological counterparts: the average cost to develop high-risk, novel medical devices is estimated to be $94 million. After all, device engineers can leverage lower-cost animal models further into development than their pharmaceutical colleagues, the human clinical trials necessary for FDA approval are often smaller in scale, and, in some cases, expenses can be defrayed by revenue generated outside the United States in markets with faster regulatory pathways.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Doctors push to include dialysis machines in emergency stockpile

WSS

New CMS data security rules will hurt Medicare, Medicaid research

Sage considers ways to reduce costs following FDA rejection

Sage considers ways to reduce costs following FDA rejection

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Kansas bar where gunfire wounded 9 last month closes permanently

Google's generative AI to analyze medical images — and talk to docs

focus

leisure time

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Opioid cravings were reduced by anti

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Measles policy set amid Florida outbreak alarms vaccine proponents

Peter Hotez and the public health issue of online harassment

Pennsylvania man bitten on the head by bear during attack in his garage

Sports medicine is finally prioritizing gender equality

Weight loss drugs aren’t covered by Obamacare. That may change

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

knowledge

Surprise medical billing ban raises prices elsewhere

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Weight loss drugs aren’t covered by Obamacare. That may change

Trump used to be more articulate. What could explain the change?

New CMS data security rules will hurt Medicare, Medicaid research

knowledge

entertainment

leisure time

entertainment